ArriVent BioPharma, Inc. ( AVBP) - Stock Earnings
AVBP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026, midnight | — / — | — | — / — | — |
AVBP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -35.0 million USD | — USD |
| 2025Q4 | -35.5 million USD | — USD |
| 2026Q1 | -43.3 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AVBP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -69.3 million USD | — USD |
| 2024 | -80.5 million USD | — USD |
| 2025 | -166.3 million USD | — USD |
| 2026 Est. | — | — |
AVBP
Price: $31.73
52 week price:
Earnings Per Share: -3.38 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.6 billion